12:00 AM
 | 
May 11, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Seasonal influenza VLP vaccine: Phase II data

Novavax began a placebo-controlled, U.S. Phase ll trial to evaluate single injections of 15 or 60 µg of seasonal influenza VLP vaccine in...

Read the full 92 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >